Key result
Type 2 diabetes linked to ~27% higher ALT levels alongside elevated atherogenic lipids.
Why the study?
In Ethiopia, large and community-based studies on type 2 diabetes and associated hepatic and metabolic impairments are lacking.
Does Type 2 Diabetes Mellitus impair liver function tests and lipid profiles compared to non-diabetic controls in adult Ethiopian patients?
Cross-Sectional (n=140)
No
Does Type 2 Diabetes Mellitus impair liver function tests and lipid profiles compared to non-diabetic controls in adult Ethiopian patients?
Answers are grounded in this paper and cite their sources.
Ethiopian patients with type 2 diabetes exhibit significantly higher liver enzyme and atherogenic lipid levels and lower HDL levels compared to non-diabetic controls, independent of anti-diabetic medication regimen.
BackgroundDiabetes Mellitus (DM) is a group of metabolic diseases characterized by increased blood glucose levels, resulting from defects in insulin secretion, insulin action, or both.Glucose is an important regulator of various pancreatic β-cell processes, including insulin biosynthesis and release.Glucose, over short intervals, stimulates insulin biosynthesis at the level of translation.Glucose thus becomes the final common pathway for the transport of almost all carbohydrates to tissue cells.Normally, rates of glucose influx into the circulation and those of glucose efflux out of the circulation into tissues other than the brain are coordinately regulated largely by the plasma glucose lowering hormone, insulin, and the plasma glucose raising hormones, glucagon and epinephrine.Thus systemic glucose balance is maintained, hypoglycemia as well as hyperglycemia is prevented, and a continuous supply of glucose to the brain is ensured.However, in diabetic patients the body's inability to effectively regulate the sugar balance leads to severe consequences such as hyperglycemia, obesity, Non-Alcoholic Fatty Liver Disease (NAFLD), osteoporosis and diabetic complications including neuropathy, nephropathy, retinopathy, cardiomyopathy, and hypoglycemic coma leading to death [1-2].In Ethiopia, although large and community based studies are lacking, in the urban community in Gondar in northern Ethiopia the prevalence of type 2 diabetes has been reported to be approximately 0.3 % [3].However, the prevalence of known diabetes amongst a rural community was as low as 0.014%.In urban areas, type 2 diabetes accounts for 71% of people with the diabetes.When compared with the urban population, the proportion of people in the rural areas who are
No takes yet. Share an insight, caveat, or question.
Zawdie Belay Seifu Daniel (2014) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=140). Type 2 Diabetes Mellitus vs. Non-diabetic controls was evaluated on Alanine aminotransferase (ALT) concentration (U/L) (95% CI 0.7-4.89, p=0.01). Type 2 diabetes patients had higher mean liver enzymes and atherogenic lipids compared to non-diabetic controls.
Synapse has enriched 10 related papers. Consider them for comparative context: